Related references
Note: Only part of the references are listed.Assessing Women at High Risk of Breast Cancer: A Review of Risk Assessment Models
Eitan Amir et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Mammographic surveillance in women younger than 50 years who have a family history of breast cancer: tumour characteristics and projected effect on mortality in the prospective, single-arm, FH01 study
LANCET ONCOLOGY (2010)
Population estimates of survival in women with screen-detected and symptomatic breast cancer taking account of lead time and length bias
Gill Lawrence et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
The Contribution of Clinical Breast Examination to the Accuracy of Breast Screening
Anna M. Chiarelli et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Polygenes, risk prediction, and targeted prevention of breast cancer
Paul D. P. Pharoah et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Surveillance for familial breast cancer:: Differences in outcome according to BRCA mutation status
Pal Moller et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
BRCA mutations in women with ductal carcinoma in situ
Karen Lisa Smith et al.
CLINICAL CANCER RESEARCH (2007)
Clinical outcomes of breast cancer in carriers of BRCA1 and BRCA2 mutations
Gad Rennert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Tumour characteristics, survival and prognostic factors of hereditary breast cancer from BRCA2-, BRCA1- and non-BRCA1/2 families as compared to sporadic breast cancer cases
C. T. M. Brekelmans et al.
EUROPEAN JOURNAL OF CANCER (2007)
Ductal carcinoma in situ in BRCA mutation carriers
E. Shelley Hwang et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Screening younger women with a family history of breast cancer - does early detection improve outcome?
A. Maurice et al.
EUROPEAN JOURNAL OF CANCER (2006)
Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS)
MO Leach et al.
LANCET (2005)
Adjusting the estimated proportion of breast cancer cases associated with BRCA1 and BRCA2 mutations: Public health implications
MR McClain et al.
GENETICS IN MEDICINE (2005)
Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination
E Warner et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Performance and reporting of clinical breast examination: A review of the literature
S McDonald et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2004)
Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme
E Amir et al.
JOURNAL OF MEDICAL GENETICS (2003)
Contribution of clinical breast examination to mammography screening in the early detection of breast cancer
C Bancej et al.
JOURNAL OF MEDICAL SCREENING (2003)
The incidence of breast cancer from screening women according to predicted family history risk: does annual clinical examination add to mammography?
GPH Gui et al.
EUROPEAN JOURNAL OF CANCER (2001)
Familial invasive breast cancers:: Worse outcome related to BRCA1 mutations
D Stoppa-Lyonnet et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Prognosis and clinical presentation of BRCA2-associated breast cancer
N Loman et al.
EUROPEAN JOURNAL OF CANCER (2000)
Guidelines for a genetic risk based approach to advising women with a family history of breast cancer
DM Eccles et al.
JOURNAL OF MEDICAL GENETICS (2000)
Share Paper
